Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular vasculature refers to the network of blood vessels supplying the eye, particularly the retina and choroid. Diagnostic visualization of this vasculature is crucial for detecting, monitoring, and understanding a wide range of ocular diseases such as diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and other vascular pathologies. Key imaging modalities include Fluorescein Angiography (FA), Optical Coherence Tomography Angiography (OCTA), Confocal Scanning Laser Ophthalmoscopy (cSLO), and Spectral-Domain Optical Coherence Tomography (SD-OCT). These techniques are used to diagnose ischemic or neovascular conditions, monitor disease progression, and guide treatment decisions.
N/A (visualization target, not a drug target directly)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular Vasculature.